Skip to main content
Premium Trial:

Request an Annual Quote

Christopher Steffen, John Hallinan

Premium

Accelrys has added Christopher Steffen to its board of directors. Steffen currently serves as chairman of electronics manufacturer Viasystems. He retired from Citicorp, where he served as vice-chairman and director, in 1996. Prior to that, Steffen held executive-level positions at Eastman Kodak, Honeywell, and Chrysler.


John Hallinan has been hired as chief financial officer for Signet Laboratories. Hallinan most recently served as interim CFO at Cambium Learning. Prior to that, he was CFO and vice president of business development at AnVil. Hallinan joins former AnVil CEO and president Richard Gill at Signet, where he is now president and CEO.

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.